Launch discount: 10 % off everything with code LAUNCH10
AHK-CU

AHK-CU

AHK-Cu swaps a glycine for alanine in the copper tripeptide and thereby turns its attention to the hair follicle.

Strength
Pack size
Quantity
Final price

On the shelf means out within 48 hours. No joke.

Shipped within 48 hours · EU only · Crypto or cash on delivery · Research use only

Overview

A single amino acid separates AHK-Cu from its well-known relative GHK-Cu: alanine sits in the first position instead of glycine, while the rest, histidine and lysine with a bound copper ion, is identical. Small as the difference is, in preclinical work it shifts the activity profile.

The focus is on hair. Cell culture studies connect AHK-Cu with two observations:

  • The growth phase of the hair follicle (anagen) lasts longer.
  • Cells of the dermal papilla, which nourish the follicle, undergo programmed cell death less often.

Some mechanisms are shared with GHK-Cu, such as the regulation of metalloproteinases and the influence on microcirculation. The available data, however, also point to effects of its own on follicle biology.

Chemically, AHK-Cu behaves like other copper tripeptides: in solution it appears bluish, and the copper is tightly bound, which keeps the compound stable under physiological conditions. As a small tripeptide it is broken down quickly, though, and accordingly has a short half-life. In research it is examined mainly topically, in preclinical models also subcutaneously.

If you search the literature on AHK-Cu, you will find far less than on GHK-Cu. Much of what is said about the molecule is carried over from its relative; specific work is essentially confined to cell culture and hair follicles.

Risk notes

AHK-Cu shares the mild profile of GHK-Cu, best documented for application to the skin. Its own evidence base is narrow and consists mostly of cell culture work; long-term human studies do not exist.

  • Injection site: redness, a feeling of pressure or a brief irritation with subcutaneous administration.
  • Copper: the copper complex can slightly intensify local irritation compared with copper-free peptide solutions. For very high or very frequent amounts the literature debates a theoretical danger of copper accumulation.
  • Short half-life: the rapid breakdown of the tripeptide means short windows of activity but does not change the mild profile.

This summary is no substitute for medical advice.

Sources

All products are intended for in-vitro research and laboratory use only. Not for human or veterinary use, not for diagnosis or treatment. The texts summarise published research and are no medical advice.